Carmine Oddis, MD
Nuclear Radiology · Macon, GANPI 1659315737
Payments from drug & device makers
Across 579 payments — averaging $73.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$32K
- Novartis$2K
- Pfizer$1K
- Medtronic$1K
- Johnson & Johnson$1K
- Actelion Pharmaceuticals US, Inc.$540
- plus $4K from 24 others
What the payments were for
- Consulting fees$1,2887%
- Travel & lodging$3,84422%
- Food & beverage$12,52871%
- Education$420%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 105 | $32,202 |
| Novartis | 48 | $2,022 |
| Pfizer | 98 | $1,418 |
| Medtronic(2 entities) | 36 | $1,403 |
| Johnson & Johnson | 76 | $1,098 |
| Actelion Pharmaceuticals US, Inc. | 20 | $540 |
| E.r. Squibb & Sons, L.L.C. | 37 | $500 |
| Merck | 29 | $499 |
| AstraZeneca | 24 | $476 |
| Boston Scientific | 19 | $390 |
| Cardiva Medical, Inc. | 14 | $342 |
| Bayer | 13 | $328 |
| Lexicon Pharmaceuticals, Inc. | 6 | $198 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $169 |
| Sanofi-aventis U.S. LLC | 9 | $158 |
| Boehringer Ingelheim | 9 | $149 |
| Kestra Medical Technology Services, Inc. | 1 | $104 |
| Amgen | 6 | $90 |
| Cordis US CORP. | 2 | $64 |
| Cvrx, Inc. | 2 | $44 |
| Philips North America LLC | 2 | $43 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 2 | $27 |
| Edwards Lifesciences | 1 | $20 |
| United Therapeutics Corporation | 1 | $14 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,432
- ENSITE PRECISION$1,918
- ENTRESTO$1,397
- Confirm Rx$416
- UPTRAVI$235
- OPSUMIT$235
- Arctic Front$195
- AFFERA MAPPING SYSTEM$173
- ARCTIC FRONT ADVANCE$160
- NA$153
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$153
- HeartMate Touch$150
- QUADRA ASSURA$146
- Rhythmia Mapping System$135
- ASSURITY$130
- Quadra Assura CRT Defibrillator$126
- FARXIGA$124
- Inpefa$124
- Kerendia$123
- ELIQUIS$122
How this compares
Too few nuclear radiology providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,672 | $1,459,572 |
| XareltoRivaroxaban | 585 | $494,362 |
| EntrestoSacubitril/Valsartan | 392 | $378,563 |
| OpsumitMacitentan | 14 | $172,877 |
| FarxigaDapagliflozin Propanediol | 104 | $71,716 |
| Flecainide Acetate | 1,453 | $56,145 |
| Repatha SureclickEvolocumab | 45 | $35,358 |
| MultaqDronedarone Hcl | 28 | $23,640 |
| Propafenone Hcl | 371 | $21,666 |
| Pyridostigmine Bromide | 630 | $16,016 |
| Amiodarone Hcl | 792 | $13,833 |
| Midodrine Hcl | 291 | $12,716 |
| Propafenone Hcl ErPropafenone Hcl | 52 | $10,840 |
| Dofetilide | 95 | $10,560 |
| JardianceEmpagliflozin | 11 | $9,321 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,418 | $1,459,5721,672 claims |
| Johnson & JohnsonXarelto | $1,098 | $494,362585 claims |
| NovartisEntresto | $2,022 | $378,563392 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $540 | $172,87714 claims |
| AstraZenecaFarxiga | $476 | $71,716104 claims |
| Sanofi-aventis U.S. LLCMultaq | $158 | $23,64028 claims |
| Boehringer IngelheimJardiance, Pradaxa | $149 | $18,35041 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few nuclear radiology providers in Georgiaon file to place this against a meaningful peer group, so we don't.
Other nuclear radiology in Macon
- David SchusterAtlanta$1.3M
- Jacques DionAtlanta$518
- Richard KellyAugusta$360
- John ArnoldCarrollton$240
- Cary NewmanThomasville$133
- Andrew TaylorAtlanta$120
- Halvor ParrisAlbany$64
- Allison HaysAlbany$48
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.